Matched Placebo
Matched Placebo is an intervention with 52 clinical trials. Currently 6 active trials ongoing. Historical success rate of 80.5%.
Success Metrics
Based on 33 completed trials
Phase Distribution
Phase Distribution
12
Early Stage
18
Mid Stage
18
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
76.7%
33 of 43 finished
23.3%
10 ended early
6
trials recruiting
52
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
VTP-1000 in Adults With Celiac Disease
Preoperative Stapokibart for Endoscopic Sinus Surgery in Chronic Rhinosinusitis With Nasal Polyps
Glucokinase Activator in Monogenic Diabetes
Phase 2 Study of NV-5138 in Adults With Treatment Resistant Depression
Efficacy and Safety Study of Benralizumab in Patient With Eosinophilic Chronic Rhinosinusitis With Nasal Polyps (ORCHID)
Clinical Trials (52)
VTP-1000 in Adults With Celiac Disease
Preoperative Stapokibart for Endoscopic Sinus Surgery in Chronic Rhinosinusitis With Nasal Polyps
Glucokinase Activator in Monogenic Diabetes
Phase 2 Study of NV-5138 in Adults With Treatment Resistant Depression
Efficacy and Safety Study of Benralizumab in Patient With Eosinophilic Chronic Rhinosinusitis With Nasal Polyps (ORCHID)
Treating People With Idiopathic Pulmonary Fibrosis With the Addition of Lansoprazole
Cannabidivarin (CBDV) vs. Placebo in Children With Autism Spectrum Disorder (ASD)
Genotype-tailored Treatment of Symptomatic Acid-Reflux in Children With Uncontrolled Asthma
First in Human SAD/MAD Safety and PK Study With Adult DMD Safety and PK Cohort
Intranasal Oxytocin vs. Placebo for the Treatment of Hyperphagia in Prader-Willi Syndrome
A Study of NST-6179 in Subjects With Intestinal Failure-Associated Liver Disease (IFALD).
REVEAL 2 Trial (Evaluation of VGX-3100 and Electroporation for the Treatment of Cervical HSIL)
Tranexamic Acid for Anaemia Trial
Randomised Study of Oral Azacitidine vs Placebo Maintenance in AML or MDS Patients After Allo-SCT
Melissa Officinalis L. Supplementation for Emotional Health and Sleep Disturbance
CHF5993 and CHF1535 pMDI on Lung Hyperinflation and Exercise Endurance Time in Subjects With COPD
A Study of VX-445 in Healthy Subjects and Subjects With Cystic Fibrosis
Oxytocin vs. Placebo for the Treatment Hyperphagia in Children and Adolescents With Prader-Willi Syndrome
Hydroxychloroquine to Prevent COVID-19 Disease Amongst Healthcare Workers
Intermediate-dose vs Standard Prophylactic Anticoagulation and Statin vs Placebo in ICU Patients With COVID-19
Drug Details
- Intervention Type
- OTHER
- Total Trials
- 52